RSV Policy Statement -Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection (vol 134, pg 415, 2014)

被引：1
|
作者：
Brady, Michael T.
机构：
来源：
PEDIATRICS | 2014年 / 134卷 / 06期
关键词：
D O I：
10.1542/peds.2014-2783
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：1221 / 1221
页数：1
相关论文
共 15 条
  • [1] Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection
    Brady, Michael T.
    Byington, Carrie L.
    Davies, H. Dele
    Edwards, Kathryn M.
    Jackson, Mary Anne
    Maldonado, Yvonne A.
    Murray, Dennis L.
    Orenstein, Walter A.
    Rathore, Mobeen H.
    Sawyer, Mark H.
    Schutze, Gordon E.
    Willoughby, Rodney E.
    Zaoutis, Theoklis E.
    Ralston, Shawn L.
    Lieberthal, Allan S.
    Meissner, H. Cody
    Alverson, Brian K.
    Baley, Jill E.
    Gadomski, Anne M.
    Johnson, David W.
    Light, Michael J.
    Maraqa, Nizar F.
    Mendonca, Eneida A.
    Phelan, Kieran J.
    Zorc, Joseph J.
    Stanko-Lopp, Danette
    Hernandez-Cancio, Sinsi
    [J]. PEDIATRICS, 2014, 134 (02) : 415 - 420
  • [2] Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection
    Caserta, Mary T.
    O'Leary, Sean T. R.
    Munoz, Flor M. M.
    Ralston, Shawn L.
    [J]. PEDIATRICS, 2023, 152 (01)
  • [3] Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study
    Elhalik, M.
    El-Atawi, K.
    Dash, S. K.
    Faquih, A.
    Satyan, A. D.
    Gourshettiwar, N.
    Khan, A.
    Varughese, S.
    Ramesh, A.
    Khamis, E.
    [J]. CANADIAN RESPIRATORY JOURNAL, 2019, 2019
  • [4] COST-EFFECTIVENESS ANALYSIS OF PALIVIZUMAB AS A PROPHYLAXIS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN HIGH-RISK LATE PRETERM INFANTS IN THE NETHERLANDS
    Langenfeld, M. K.
    Visser, S.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A372 - A372
  • [5] Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants
    Gaetano Chirico
    Roberto Ravasio
    Urbano Sbarigia
    [J]. Italian Journal of Pediatrics, 35
  • [6] Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants
    Chirico, Gaetano
    Ravasio, Roberto
    Sbarigia, Urbano
    [J]. ITALIAN JOURNAL OF PEDIATRICS, 2009, 35
  • [7] Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections
    Rodriguez, WJ
    Gruber, WC
    Welliver, RC
    Groothuis, JR
    Simoes, EAF
    Meissner, HC
    Hemming, VG
    Hall, CB
    Lepow, ML
    Rosas, AJ
    Robertsen, C
    Kramer, AA
    Kim, HW
    Arrobio, J
    Milburn, C
    Baker, J
    Satterwhite, P
    Steel, L
    Bender, P
    King, S
    Levin, M
    Aronoff, S
    Baer, L
    Sanchez, J
    Top, FH
    Hensen, SA
    Peterson, MB
    [J]. PEDIATRICS, 1997, 99 (03) : 454 - 461
  • [8] Age-specific hospitalization risk of primary and secondary respiratory syncytial virus infection among young children
    Nakajo, Ko
    Nishiura, Hiroshi
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 124 : 14 - 20
  • [9] Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses
    Wang, D.
    Bayliss, S.
    Meads, C.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2011, 15 (05) : 1 - +
  • [10] Incidence of respiratory syncytial virus-related hospitalizations in high-risk children:: Follow-up of a national cohort of infants treated with palivizumab as RSV prophylaxis
    Lacaze-Masmonteil, T
    Rozé, JC
    Fauroux, B
    [J]. PEDIATRIC PULMONOLOGY, 2002, 34 (03) : 181 - 188
12